Acute Pulmonary Embolism

Company gets approval for Cleactor Inj in Japan

Published in Drug Week, September 2nd, 2005

Eisai Co., Ltd., announced that it received an approval letter dated July 25, 2005, from the Ministry of Health, Labour and Welfare in Japan for thrombolytic agent Cleactor Inj for the indication of lysis of pulmonary artery thrombosis caused by acute pulmonary embolism in the presence of hemodynamic instability.

This product is available in 3 intravenous dosage forms: Cleactor Inj 400,000; Cleactor Inj 800,000; and Cleactor Inj 1,600,000.

Cleactor Inj was launched with the indication of lysis of coronary thrombus caused by acute myocardial infarction (within 6 hours after onset of symptoms) in June 1998. It has been under development for treatment...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Drug Week

Source: Drug Week (2005-09-02)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry